The Journal of Pain
Volume 3, Issue 5 , Pages 369-376 , October 2002

Sympathetic-independent bradykinin mechanical hyperalgesia induced by subdiaphragmatic vagotomy in the rat

Received 5 May 2001 ,Revised 10 January 2002 ,Accepted 10 January 2002.

References 

  1. Aley KO, McCarter G, Levine JD. Nitric oxide signaling in pain and nociceptor sensitization in the rat. J Neurosci. 1998;18:7008–7014
  2. Babenko V, Graven-Nielsen T, Svensson P, Drewes AM, Jensen TS, Arendt-Nielsen L. Experimental human muscle pain and muscular hyperalgesia induced by combinations of serotonin and bradykinin. Pain. 1999;82:1–8
  3. Babenko V, Svensson P, Graven-Nielsen T, Drewes AM, Jensen TS, Arendt-Nielsen L. Duration and distribution of experimental muscle hyperalgesia in humans following combined infusions of serotonin and bradykinin. Brain Res. 2000;853:275–281
  4. Baron R, Jänig W, Kollmann W. Sympathetic and afferent somata projecting in hindlimb nerves and the anatomical organization of the lumbar sympathetic nervous system of the rat. J Comp Neurol. 1988;275:460–468
  5. Bastian S, Paquet JL, Robert C, Cremers B, Loillier B, Larrivee JF, et al. Interleukin 8 (IL-8) induces the expression of kinin B1 receptor in human lung fibroblasts. Biochem Biophys Res Commun. 1998;253:750–755
  6. Campos MM, Souza GE, Calixto JB. Modulation of kinin B1 but not B2 receptors-mediated rat paw edema by IL-1beta and TNF-alpha. Peptides. 1998;19:1269–1276
  7. Gebhart GF, Randich A. Vagal modulation of nociception. Am Pain Soc J. 1992;1:26–32
  8. Glass DB, Lundquist LJ, Katz BM, Walsh DA. Protein kinase inhibitor-(6-22)-amide peptide analogs with standard and nonstandard amino acid substitutions for phenylalanine 10: Inhibition of cAMP-dependent protein kinase. J Biol Chem. 1989;264:14579–14584
  9. Gonzales R, Goldyne ME, Taiwo YO, Levine JD. Production of hyperalgesic prostaglandins by sympathetic postganglionic neurons. J Neurochem. 1989;53:1595–1598
  10. Jensen K, Tuxen C, Pedersen-Bjergaard U, Jansen I. Pain, tenderness, wheal and flare induced by substance-P, bradykinin and 5-hydroxytryptamine in humans. Cephalalgia. 1991;11:175–182
  11. Khasar SG, McCarter G, Levine JD. Epinephrine produces a beta-adrenergic receptor-mediated mechanical hyperalgesia and in vitro sensitization of rat nociceptors. J Neurophysiol. 1999;81:1104–1112
  12. Khasar SG, Miao FJ-P, Jänig W, Levine JD. Modulation of bradykinin-induced mechanical hyperalgesia in the rat by activity in abdominal vagal afferents. Eur J Neurosci. 1998;10:435–444
  13. Khasar SG, Miao FJ-P, Jänig W, Levine JD. Vagotomy-induced enhancement of mechanical hyperalgesia in the rat is sympathoadrenal-mediated. J Neurosci. 1998;18:3043–3049
  14. Khasar SG, Miao FJ-P, Levine JD. Inflammation modulates the contribution of receptor-subtypes to bradykinin-induced hyperalgesia in the rat. Neuroscience. 1995;69:685–690
  15. Khasar SG, Ouseph AK, Chou B, Ho T, Green PG, Levine JD. Is there more than one prostaglandin E receptor subtype mediating hyperalgesia in the rat hindpaw?. Neuroscience. 1995;64:1161–1165
  16. Khasar SG, Wang JF, Taiwo YO, Heller PH, Green PG, Levine JD. Mu-opioid agonist enhancement of prostaglandin-induced hyperalgesia in the rat: A G-protein beta gamma subunit-mediated effect?. Neuroscience. 1995;67:189–195
  17. Lembeck F, Popper H, Juan H. Release of prostaglandins by bradykinin as an intrinsic mechanism of its algesic effect. Naunyn Schmiedebergs Arch Pharmacol. 1976;294:69–73
  18. Levine JD, Taiwo YO. Involvement of the mu-opiate receptor in peripheral analgesia. Neuroscience. 1989;32:571–575
  19. Levine JD, Taiwo YO, Collins SD, Tam JK. Noradrenaline hyperalgesia is mediated through interaction with sympathetic postganglionic neurone terminals rather than activation of primary afferent nociceptors. Nature. 1986;323:158–160
  20. Manning DC, Raja SN, Meyer RA, Campbell JN. Pain and hyperalgesia after intradermal injection of bradykinin in humans. Clin Pharmacol Ther. 1991;50:721–729
  21. Martin HA, Basbaum AI, Kwiat GC, Goetzl EJ, Levine JD. Leukotriene and prostaglandin sensitization of cutaneous high-threshold C- and A-delta mechanonociceptors in the hairy skin of rat hindlimbs. Neuroscience. 1987;22:651–659
  22. Miao FJ, Jänig W, Dallman MF, Benowitz NL, Heller PH, Basbaum AI, et al. Role of vagal afferents and spinal pathways modulating inhibition of bradykinin-induced plasma extravasation by intrathecal nicotine. J Neurophysiol. 1994;72:1199–1207
  23. Perkins MN, Kelly D. Induction of bradykinin B1 receptors in vivo in a model of ultra-violet irradiation-induced thermal hyperalgesia in the rat. Br J Pharmacol. 1993;110:1441–1444
  24. Petersen M, Eckert AS, Segond von Banchet G, Heppelmann B, Klusch A, Kniffki KD. Plasticity in the expression of bradykinin binding sites in sensory neurons after mechanical nerve injury. Neuroscience. 1998;83:949–959
  25. Petersen M, Segond von Banchet G, Heppelmann B, Koltzenburg M. Nerve growth factor regulates the expression of bradykinin binding sites on adult sensory neurons via the neurotrophin receptor p75. Neuroscience. 1998;83:161–168
  26. Prechtl JC, Powley TL. Organization and distribution of the rat subdiaphragmatic vagus and associated paraganglia. J Comp Neurol. 1985;235:182–195
  27. Prechtl JC, Powley TL. Organization and distribution of the rat subdiaphragmatic vagus and associated paraganglia. Brain Res. 1986;367:192–200
  28. Regoli DC, Marceau F, Lavigne J. Induction of beta 1-receptors for kinins in the rabbit by a bacterial lipopolysaccharide. Eur J Pharmacol. 1981;71:105–115
  29. Sardi SP, Ares VR, Errasti AE, Rothlin RP. Bradykinin B1 receptors in human umbilical vein: Pharmacological evidence of up-regulation, and induction by interleukin-1 beta. Eur J Pharmacol. 1998;358:221–227
  30. Seabrook GR, Bowery BJ, Heavens R, Brown N, Ford H, Sirinathsinghi DJ, et al. Expression of B1 and B2 bradykinin receptor mRNA and their functional roles in sympathetic ganglia and sensory dorsal root ganglia neurones from wild-type and B2 receptor knockout mice. Neuropharmacology. 1997;36:1009–1017
  31. Taiwo YO, Bjerknes LK, Goetzl EJ, Levine JD. Mediation of primary afferent peripheral hyperalgesia by the cAMP second messenger system. Neuroscience. 1989;32:577–580
  32. Taiwo YO, Coderre TJ, Levine JD. The contribution of training to sensitivity in the nociceptive paw-withdrawal test. Brain Res. 1989;487:148–151
  33. Taiwo YO, Goetzl EJ, Levine JD. Hyperalgesia onset latency suggests a hierarchy of action. Brain Res. 1987;423:333–337
  34. Taiwo YO, Heller PH, Levine JD. Characterization of distinct phospholipases mediating bradykinin and noradrenaline hyperalgesia. Neuroscience. 1990;39:523–531
  35. Taiwo YO, Heller PH, Levine JD. Mediation of serotonin hyperalgesia by the cAMP second messenger system. Neuroscience. 1992;48:479–483
  36. Taiwo YO, Levine JD. Contribution of guanine nucleotide regulatory proteins to prostaglandin hyperalgesia in the rat. Brain Res. 1989;492:400–403
  37. Taiwo YO, Levine JD. Further confirmation of the role of adenyl cyclase and of cAMP-dependent protein kinase in primary afferent hyperalgesia. Neuroscience. 1991;44:131–135
  38. Toullec D, Pianetti P, Coste H, Bellevergue P, Grand PT, Ajakane M, et al. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem. 1991;266:15771–15781
  39. Tsapis A, Kepes A. Transient breakdown of the permeability barrier of the membrane of Escherichia coli upon hypoosmotic shock. Biochim Biophys Acta. 1977;469:1–12
  40. Watkins LR, Wiertelak EP, Goehler LE, Mooney HK, Martinez J, Furness L, et al. Neurocircuitry of illness-induced hyperalgesia. Brain Res. 1994;639:283–299

☆ Supported by NIH Grant #NR 004880.

☆☆ Address reprint requests to Jon D. Levine, MD, PhD, UCSF NIH Pain Center, Box 0440, C-522, University of California, San Francisco, CA 94143-0440. E-mail: levine@itsa.ucsf.edu

★ 1526-5900/2002 $35.00/0

PII: S1526-5900(02)00031-7

doi: 10.1054/jpai.2002.126610

The Journal of Pain
Volume 3, Issue 5 , Pages 369-376 , October 2002

Article Tools

* Image Usage & Resolution